Systematic review of the clinical effectiveness and cost-effectiveness, and economic evaluation, of denosumab for the treatment of bone metastases from solid tumours

Ford, J, Cummins, E, Sharma, P, Elders, A, Stewart, F, Johnston, R, Royle, P, Jones, R, Mulatero, C, Todd, R and Mowatt, G (2013) Systematic review of the clinical effectiveness and cost-effectiveness, and economic evaluation, of denosumab for the treatment of bone metastases from solid tumours. Health Technology Assessment, 17 (29). pp. 1-386. ISSN 1366-5278

Full text not available from this repository. (Request a copy)

Abstract

Denosumab offers an alternative, or additional, treatment for the prevention of skeletal-related events (SREs) in patients with bone metastases from solid tumours.

Item Type:	Article
Uncontrolled Keywords:	antibodies, monoclonal, humanized,bone density conservation agents,bone neoplasms,breast neoplasms,cost-benefit analysis,female,humans,lung neoplasms,male,models, economic,prostatic neoplasms,quality-adjusted life years,randomized controlled trials as topic
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School Faculty of Science > School of Chemistry
Depositing User:	Pure Connector
Date Deposited:	12 Nov 2014 16:50
Last Modified:	21 Oct 2022 00:15
URI:	https://ueaeprints.uea.ac.uk/id/eprint/50668
DOI:	10.3310/hta17290

Actions (login required)

View Item